Peaks of Interest
LECO Corporation (St. Joseph, Missouri) recently opened a global support center at its headquarters to serve domestic and international customers. The building will house its service, customer training, and consumables departments. An auditorium, training rooms, cafeteria, and restrooms have been designed exclusively for customers attending training classes. Up-to-date technology has been installed to ensure service and training needs for all customers are met quickly and efficiently.
LECO opens global support center
LECO Corporation (St. Joseph, Missouri) recently opened a global support center at its headquarters to serve domestic and international customers. The building will house its service, customer training, and consumables departments. An auditorium, training rooms, cafeteria, and restrooms have been designed exclusively for customers attending training classes. Up-to-date technology has been installed to ensure service and training needs for all customers are met quickly and efficiently.
Chromatography Market Profile
Eksigent and Applied Biosystems announce distribution agreement
Eksigent Technologies (Livermore, California) recently announced a distribution agreement with Applied Biosystems/MDS SCIEX (Foster City, California). Applied Biosystems will offer a new line of high performance liquid chromatography systems based upon Eksigent's proprietary technology integrated with Applied Biosystems/MDS SCIEX mass spectrometers.
The new Tempo liquid chromatography (LC) systems will be sold and serviced by Applied Biosystems/MDS SCIEX, and include platforms for nano LC, high-throughput micro LC, and an LC–MALDI deposition system. The systems are based upon Eksigent's Microfluidic Flow Control technology, which has been widely adopted in proteomics research and in pharmaceutical discovery applications.
Fisher Biosciences collaborates with Dyomics
Fisher Biosciences (Pittsburgh, Pennsylvania) recently announced a collaboration with Dyomics GmbH (Jena, Germany), a developer and manufacturer of fluorescent dyes and other markers for biomolecular research. This collaboration will enable Fisher to develop and manufacture an expanded range of products for protein and nucleic-acid detection under the Pierce brand.
Dyomics' products are used in a number of scientific-research, drug-discovery, and diagnostic applications.
Under the Pierce brand, Fisher currently offers protein-research products based primarily upon chemiluminescent and colorimetric detection and will expand to offer fluorescently labeled reagents.
National City and PerkinElmer announce partnership
National City Commercial Capital (Cleveland, Ohio) recently announced a financing partnership with the Life and Analytical Sciences division of PerkinElmer (Shelton, Conneticut). National City Commercial Capital will provide custom-financing programs for PerkinElmer customers.
National City Commercial Capital is a subsidiary of National City Corporation and is one of the largest bank-affiliated leasing companies in the country.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.
